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Abstract: Epidermolysis bullosa simplex with mottled hyperpigmenta-
tion (EBS-MP) is an uncommon subtype of EBS. Its clinical features depend
on the age of diagnosis, and clinical variations have been described even
within family members. We present six cases from two unrelated Spanish
families each with several affected members with EBS-MP and review the
clinical and genetic findings in all reported patients. We highlight the
changing clinical features of the disease throughout life.
Epidermolysis bullosa simplex with mottled hyper-
pigmentation (EBS-MP) is a rare subtype ofEBS (Online
Mendelian Inheritance in Man [OMIM] no. 131960).
Since its first description in1979 (1),multiple families and
some sporadic cases have been reported from all over the
world. Clinical heterogeneity regarding skin features and
age of presentation is recognized, as well as additional
manifestations such as photosensitivity (2) and dental
disorders (1,3). Classic clinical features in most patients
include serous, nonscarring blisters on the distal part of
the extremities and slowly progressing reticular hyper-
pigmentation. Blisters usually appear at birth or in early
infancy, tend to decrease with age, and only occasionally
appear in adults, after minor trauma or friction. The
hyperpigmented lesions appear later in infancy or
childhood, spread slowly, and tend to greatly lessen
eventually but do not disappear. Many adults also de-
velop focal palmoplantar hyperkeratosis.
We report six cases of EB-MP in two unrelated
Spanish families with several affected members with
EBS-MP and review all cases previously reported. In
both families, the autosomal-dominant missense
p.Pro25Leu mutation in the head domain of KRT5,
commonly associated with this subtype, was present in
all affected individuals in whom a genetic analysis was
performed (4).
CASE REPORTS
The pedigrees of both families are shown in Fig. 1.
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Family 1
Patient 1 A 2-month-old girl presented with a history
of blisters and a few erosive lesions with crusted surface
since birth. The majority of lesions were located on the
face (cheeks and perioral region) and frictional areas
such as the diaper area, palms, and soles. Lesions healed
without scar formation or milia, and the surrounding
skin was normal. There was no nail or mucous involve-
ment, and skin color was normal (Fig. 2).
Patient 2 A 2-year-old otherwise healthy girl, the older
sister of patient 1, had a recent history of progressive
hyperpigmented lesions.Theywere asymptomatic brown
to tan, confluent, reticulatedmacules, favoring theaxillae
and groin, but also appearing on the flexural areas and
extremities. She had a past history of nonscarring blisters
since birth on both palms and soles, and on physical
examination tense bullae on both soles were observed
(Fig. 3A,B).
Patient 3 A 30-year-old woman, the mother of the
siblings described above, had persistent brownish mot-
tled hyperpigmentation on the groins, armpits, and neck
folds and palmoplantar hyperkeratotic papules (Fig.
3C,D). She did not remember blistering in infancy or
early childhood. The older brother of this patient, now
40 years old,was reported tohave similar lesions butwas
unavailable for clinical examination.
Family 2
Patient 1 A 2-year-old boy presented with a recent
history of progressive hyperpigmented, confluent, lesions
mostly on his arms and legs. His past history was remark-
able for skin fragility and bullae formation since birth.
Patient 2 The mother of patient 1 showed the similar
hyperpigmented macules on the extremities, as well as
hyperkeratotic papules on both palms and soles. She
remembered that her mother had had similar clinical
features (Fig. 4A,B).
Patient 3 The cousin of patient 1 had clinically non-
scarring blisters on pressure areas and a few erosions
(Fig. 4C,D).
HISTOLOGIC AND MOLECULAR ANALYSIS
Askinbiopsywas taken fromhyperpigmented lesions on
the axilla of patient 3 from family 1. There were elon-
gated lentiginous rete ridges with some ectatic epidermal
follicles and scatteredmelanin-loadeddermal histiocytes.
???????????
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Figure 1. Clinical pedigree of three generations of both
families.
? ?
? ?
Figure 2. Clinical findings in patient 1 (2-month-old girl), family 1: a few nonscarring perioral blisters (A), erosion on the kneewith
normal surrounding skin (B), and blisters on the ankle (C) and both feet (D).
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Genomic DNA (gDNA) from the six patients described
herein was screened by direct sequencing for the most
common mutation that has been associated with EBS-
MP (5)—KRT5 p.Pro25Leu. In all of the samples, a
heterozygousC toT transitionwasdetected at nucleotide
74of theKRT5gene, resulting inproline to leucine amino
acid substitutionat the conserved reside 25of keratinK5.
DISCUSSION
Clinical manifestations of EBS-MP vary according
to patient age, and there is phenotype heterogeneity
between members of the same affected family and of
different families. Since the first family reported (1), only
15 families and eight sporadic cases of EBS-MP have
? ?
? ?
Figure 3. (A,B) Clinical findings in patient 2 (2-year-old girl), family 1. (C,D) Clinical findings in patient 3 (30-year-old woman),
family 1.
? ?
? ?
Figure 4. (A,B) Clinical findings in patient 2, family 2 (35-year-oldwoman). (C,D) Clinical findings in patient 3, family 2 (6-year-old
boy).
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been described (1–22), including the twoSpanish families
described in the present report (4), (Table 1). In all re-
ported cases for which history is available, the blisters
appeared at birth or during infancy and tended to dis-
appear in adulthood, although in some cases they reap-
peared periodically (1,6). The blisters are usually
localized, affecting mainly the distal extremities or acral
areas, although generalized blistering has been reported
in two families (1,7) and in one sporadic case (3). Blisters
heal without scarring, but in the first reported family and
in one spontaneous case, physical examination revealed
milia (1,8), and in this latter case and in two other re-
ported cases, cutaneous atrophy was also found (9).
Some authors (6,10,11) noticed more blisters during
summertime, but this situation is not consistently re-
corded. In our cases, the two siblings of family 1 and the
two cousins of family 2 had had blisters since birth that
healed without milia or scarring, and in family 1, the
blisters were more generalized in the younger patient
than inher older sister,whoseblisters fadedwith age, and
appeared only on pressure areas.
Abnormal skin pigmentation appears later in life and
is not preceded by blisters. In all reported cases, it is
described as hyperpigmented and confluent macules
forming a reticular pattern that in some cases may be
accompanied by hypopigmented macules (3,7,12).
According to previous reports, the most commonly in-
volved areas are the trunk (3,5,6,9,11–15) and the
extremities (1,5,6,10–12,14–17), followed by the abdo-
men (8,18) and the armpits and groin (2,19). In some
cases, this hyperpigmentation can progress and involve
most of the body surface (7,20).
During adolescence and adulthood, patients may
have hyperkeratotic lesions that are most commonly
found on the palms and soles. As shown inTable 1, some
families lack this clinical feature (2,3,5,6,10,11,15,18,22),
whereas the majority of adult members in other families
have such lesions (1,7–9,12–17,19,20). In our cases, the
siblings were too young to have manifestations of the
potential predicted phenotype.
Nail alterations have also been described in some
individuals with EBS-MP (1,3,5,7–9,13,15,16,18,20),
although it is not a consistent feature. Other uncommon
clinicalfindingswere caries (1,3,9,16), found in fourcases,
and photosensitivity and telangiectasias (2,3), described
in only two patients. Finally, in one sporadic case in a
3-year-oldboy,attenuateddermatoglyphicson thehands
and erosive blepharitis of the left eye were found (10).
Apart from the above-described clinical findings and
the family history, antigen mapping and especially
molecular analysis are critical to achieving the correct
diagnosis (11). Genetically, the mutation most com-
monly found in EBS-MP is the p.Pro25Leu mutation,
which affects the keratin K5 protein (23) (http://
www.interfil.org). This mutation is thought to produce
defective keratin filaments that produce an aberrant
melanosome uptake, resulting in hyperpigmented areas
(5,14). The description of mutations underlying EBS-
MP distinct to pPro25Leu suggests that other keratin
domains might be involved in the process of pigment
distribution. Other mutations have been reported. Hor-
iguchi and colleagues (6) described a newmutation in the
KRT5 gene (c.1649delG) affecting the tail domain of the
keratin K5 (p.Gly550AlafsX77) in two cousins, and
Tang and colleagues (18) identified the samemutation in
another familiar case. Twomutations associatedwith the
KRT14 gene have also been reported. Harel and col-
leagues (12) found a heterozygous T to C transition at
position 356 of the KRT14 gene that results in the sub-
stitution of a highly conserved residue (p.M119T), and
Arin and colleagues (21) noticed a duplication
(c.1117_1158dup42) at the central 2B domain of keratin
K14 (p.Ile373Glu386dup). Accordingly, it has been
suggested that haploinsufficiency of keratin K5, as
reported in patients with another genodermatosis asso-
ciated with a reticulate pigmentary defect such as Dow-
ling-Degos disease, may alter keratinocyte organization
and adhesion, as well as melanosome uptake by kerati-
nocytes and longevity of melanin granules in basal layer
cells (24). This hypothesis would explain bullae forma-
tion in EBS-MP and the co-occurrence of hyperpig-
mentation (5,24). Furthermore, it has been postulated
that palmoplantar hyperkeratotic lesions in EBS-MPare
the consequence of abnormal binding between the ker-
atin filaments of the keratinocytes and the desmosomes
(19). The relationship between the rather constant ge-
netic mutations and the variable phenotype is not clearly
addressed, and some other modulating genes or envi-
ronmental factors might play a role in such variable
clinical expression.
In children, the main differential diagnosis is other
types of EBS, principally the herpetiformis type of
Dowling-Meara (EBS-DM; OMIM no. 131760), and
Kindler syndrome (KS; OMIM no. 173650) (25). In the
EBS-DM with mottled pigmentation the hyperpigmen-
tation seems to be postinflammatory, and the blisters
have a typical herpetiform pattern (26). Genetically,
mutations at the highly conserved ends (helix initiation
and helix termination peptides) of the alpha-helical rod
domain ofKRT5 andKRT14 genes cause EBS-DM(21).
These highly conserved ends are crucial for keratin
filament assembly, and their mutations involve a
more-generalized and severe phenotype of epidermolysis
bullosa. KS is an autosomal-recessive genodermatosis
clinically characterized by acral bullae in infancy and
early childhood, generalized progressive poikiloderma,
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reticulatedpigmentationof theneck and face, anddiffuse
cutaneous atrophy. Genetic testing can be considered to
exclude KS, which is caused by a mutation in the FER-
MT1 (kindlin) gene (27).
In adults, the main differential diagnosis is Dowling-
Degos disease (DDD;OMIMno. 179850).Mutations in
the KRT5 gene are also found in DDD (http://www.in-
terfil.org) (28), but these affect domains other than the
rod ends (24). In conclusion, early blistering cannot
predict ultimate phenotype. Assessing phenotypic vari-
ability, family history andmutation analysis can assist in
diagnosis.
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